Insider Buy/Sell Ratio - USA Drug Manufacturers, CFO : 0.25 (As of 2025-01-01)
Basic Info
Insider Buy/Sell Ratio - USA Drug Manufacturers, CFO was 0.25 as of 2025-01-01, according to GuruFocus. Historically, Insider Buy/Sell Ratio - USA Drug Manufacturers, CFO reached a record high of 3 and a record low of 0.07, the median value is 0.38. Typical value range is from 0.07 to 1.07. The Year-Over-Year growth is -62.59%. GuruFocus provides the current actual value, an historical data chart and related indicators for Insider Buy/Sell Ratio - USA Drug Manufacturers, CFO - last updated on 2025-01-01.
Monthly data, but the recent month data is updated daily. Note that the monthly insider buy/sell ratio for the current month is calculated based on insider buy/sell transactions within 30 days.
| Category | Market Trend |
| Region | USA |
| Source | GuruFocus |
Stats
| Name | Value | ||
|---|---|---|---|
| Last Value | 0.25 | ||
| Latest Period | 2025-01-01 | ||
| Long Term Average | 0.56 | ||
| Average Annualized Growth Rate | -6.53% | ||
| Value from 1 year ago | 1 | ||
| Change from 1 year ago | -75% | ||
| Frequency | Daily | ||
| Unit |
Related Indicators
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers